Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Latanoprost may cause scalp inflammation and delayed healing.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

Hydroxychloroquine may help treat alopecia areata in children.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Using longer PEG chains helps nanoparticles penetrate hair follicles better, improving drug delivery for conditions like alopecia.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Niosomes are a promising and effective way to deliver drugs through the skin.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Microparticles help caffeic acid stay longer in hair follicles for better treatment of folliculitis.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Minoxidil use can cause trichostasis spinulosa in long-term hair loss patients.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.